ema semaglutide EU investigates Ozempic, weight-loss drug Saxenda after suicidal thoughts reported EMA reviewing data after reports

Obesity also drives up blood pressure by increasing salt retention and overactivating the nervous system

Dyspepsia: 11% of patients in the Wegovy group compared to 3% in the placebo group

Using it for this condition can lead to serious health issues, so its essential to use the right medication for the right diagnosis

However, coverage for the CV indication varies by plansome MA plans have added Wegovy for cardiovascular risk reduction to their formularies while others have not

If the vial is multidose, make a note about when the vial was first opened

However, as gallbladder disease is not an issue with sodium-glucose co-transporter-2 (SGLT-2) inhibitors (with similar weight loss) (89), and gallbladder events also occurred in GLP-1RA-treated patients well after weight reduction (90), other mechanisms are possibly in play